日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Concurrent water T(2) and fat fraction mapping of the breast using the radial gradient and spin echo (RADGRASE) pulse sequence

利用径向梯度和自旋回波（RADGRASE）脉冲序列同时进行乳腺水T2和脂肪分数成像

期刊:Magnetic Resonance Imaging
影响因子:2
doi:10.1016/j.mri.2025.110355
Hagio, Tomoe; Galons, Jean-Philippe; Roe, Denise; Marron, Marylin T; Thomson, Cynthia; Thompson, Patricia; Stopeck, Alison T; Bilgin, Ali; Altbach, Maria I; Chiang, Jing-Tzyh Alan
RAS
发表日期：2025
文献求助 收藏

Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer

图卡替尼、来曲唑和帕博西尼治疗既往接受过治疗的HR+/HER2+乳腺癌患者的安全性和有效性

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-0117
Shagisultanova, Elena; Gradishar, William; Brown-Glaberman, Ursa; Chalasani, Pavani; Brenner, Andrew J; Stopeck, Alison; Parris, Hannah; Gao, Dexiang; McSpadden, Tessa; Mayordomo, Jose; Diamond, Jennifer R; Kabos, Peter; Borges, Virginia F
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval

获批后 10 年内，使用地诺单抗 (XGEVA®) 预防骨骼相关事件的经验

期刊:Journal of Bone Oncology
影响因子:3.5
doi:10.1016/j.jbo.2022.100416
Cadieux, Benoit; Coleman, Robert; Jafarinasabian, Pegah; Lipton, Allan; Orlowski, Robert Z; Saad, Fred; Scagliotti, Giorgio V; Shimizu, Kazuyuki; Stopeck, Alison
发表日期：2022
文献求助 收藏

Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach

实体瘤骨转移患者停用地诺单抗治疗后骨骼相关事件的风险因素：一种基于真实世界机器学习方法的研究

期刊:Journal of Bone Oncology
影响因子:3.5
doi:10.1016/j.jbo.2022.100423
Jacobson, Dionna; Cadieux, Benoit; Higano, Celestia S; Henry, David H; Bachmann, Basia A; Rehn, Marko; Stopeck, Alison T; Saad, Hossam
发表日期：2022
文献求助 收藏

Case report: Metastatic metaplastic breast cancer with choriocarinomatous features: Targeting the choriocarcinoma component for cure

病例报告：伴有绒毛膜癌特征的转移性化生性乳腺癌：靶向治疗绒毛膜癌成分以期治愈

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.1061679
Mehta, Krisha K; Nouvini, Rosa; Liu, Jingxuan; Wang, Yi; Stopeck, Alison
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Two fully automated data-driven 3D whole-breast segmentation strategies in MRI for MR-based breast density using image registration and U-Net with a focus on reproducibility

本文提出了两种全自动、数据驱动的三维全乳分割策略，用于基于磁共振成像的乳腺密度评估，分别采用图像配准和U-Net网络，并着重研究了分割结果的可重复性。

期刊:Visual Computing for Industry, Biomedicine, and Art
影响因子:3.2
doi:10.1186/s42492-022-00121-4
Ying, Jia; Cattell, Renee; Zhao, Tianyun; Lei, Lan; Jiang, Zhao; Hussain, Shahid M; Gao, Yi; Chow, H-H Sherry; Stopeck, Alison T; Thompson, Patricia A; Huang, Chuan
发表日期：2022
文献求助 收藏

Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer

舒林酸可改善服用芳香化酶抑制剂治疗乳腺癌女性的僵硬症状和生活质量

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06485-0
Martinez, Jessica A; Wertheim, Betsy C; Roe, Denise J; Chalasani, Pavani; Cohen, Jules; Baer, Lea; Chow, H-H Sherry; Stopeck, Alison T; Thompson, Patricia A
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment

血浆来源的细胞外囊泡 (BEV)：颗粒纯化液相色谱 (PPLC) 和蛋白质组学分析表明，BEV 是预测乳腺癌治疗反应的潜在微创工具

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-022-06733-x
Folnetti A Alvarez, Hussein Kaddour, Yuan Lyu, Christina Preece, Jules Cohen, Lea Baer, Alison T Stopeck, Patricia Thompson, Chioma M Okeoma
肿瘤
乳腺癌
其它细胞
FCM
IF
IHC-P
WB
Human
APOA1
发表日期：2022
文献求助 收藏

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

一项评估舒尼替尼苹果酸盐联合每周一次紫杉醇、序贯多柔比星和每日口服环磷酰胺加粒细胞集落刺激因子（G-CSF）作为局部晚期或炎性乳腺癌新辅助化疗方案的安全性和有效性的II期研究

期刊:Clinical Breast Cancer
影响因子:2.5
doi:10.1016/j.clbc.2021.05.009
Symonds, Lynn; Jenkins, Isaac; Linden, Hannah M; Kurland, Brenda; Gralow, Julie R; Gadi, Vijayakrishna V K; Ellis, Georgiana K; Wu, Qian; Rodler, Eve; Chalasani, Pavani; Chai, Xiaoyu; Riedel, Jinny; Scca Network Investigators; Stopeck, Alison; Brown-Glaberman, Ursa; Specht, Jennifer M
肿瘤
G-CSF
肿瘤免疫
乳腺癌
粒细胞
细胞生物学
发表日期：2022
文献求助 收藏

Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors

舒林酸是一种非选择性非甾体抗炎药，可降低接受芳香化酶抑制剂治疗的绝经后乳腺癌女性的乳腺密度。

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-0732
Thompson, Patricia A; Huang, Chuan; Yang, Jie; Wertheim, Betsy C; Roe, Denise; Zhang, Xiaoyue; Ding, Jie; Chalasani, Pavani; Preece, Christina; Martinez, Jessica; Chow, H-H Sherry; Stopeck, Alison T
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏